# Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women

> **NCT01080300** · PHASE3 · COMPLETED · sponsor: **Depomed** · enrollment: 600 (actual)

## Conditions studied

- Hot Flashes

## Interventions

- **DRUG:** Gabapentin Extended Release
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01080300
- **Lead sponsor:** Depomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2020-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01080300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01080300, "Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01080300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*